Wearable Electrochemical Biosensors for Advanced Healthcare Monitoring
Advanced Science,
Год журнала:
2024,
Номер
12(2)
Опубликована: Ноя. 26, 2024
Abstract
Recent
advancements
in
wearable
electrochemical
biosensors
have
opened
new
avenues
for
on‐body
and
continuous
detection
of
biomarkers,
enabling
personalized,
real‐time,
preventive
healthcare.
While
glucose
monitoring
has
set
a
precedent
biosensors,
the
field
is
rapidly
expanding
to
include
wider
range
analytes
crucial
disease
diagnosis,
treatment,
management.
In
this
review,
recent
key
innovations
are
examined
design
manufacturing
underpinning
these
biosensing
platforms
including
biorecognition
elements,
signal
transduction
methods,
electrode
substrate
materials,
fabrication
techniques.
The
applications
then
highlighted
detecting
variety
biochemical
markers,
such
as
small
molecules,
hormones,
drugs,
macromolecules,
biofluids
interstitial
fluid,
sweat,
wound
exudate,
saliva,
tears.
Additionally,
review
also
covers
advances
platforms,
multi‐sensory
integration,
closed‐loop
control,
power
supply.
Furthermore,
challenges
associated
with
critical
issues
discussed,
biocompatibility,
biofouling,
sensor
degradation,
opportunities
materials
science,
nanotechnology,
artificial
intelligence
overcome
limitations.
Язык: Английский
Recent advances and future prospects of wearable sensors based on nanomaterial sensing mechanisms for biosafety monitoring
Chemical Engineering Journal,
Год журнала:
2025,
Номер
unknown, С. 162695 - 162695
Опубликована: Апрель 1, 2025
Язык: Английский
Electrochemical biosensors for enhanced detection of diabetes mellitus
Clinica Chimica Acta,
Год журнала:
2025,
Номер
unknown, С. 120221 - 120221
Опубликована: Фев. 1, 2025
Язык: Английский
Polymeric sensors for blood analysis: current and future scope of research
Polymer International,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 28, 2025
Abstract
This
review
explores
the
advancements
in
polymer‐based
sensors
for
blood
analysis,
emphasizing
online
detection
of
key
components
such
as
uric
acid,
creatinine,
urea,
bilirubin,
cholesterol,
total
proteins,
amino
acids
and
hormones.
It
categorizes
polymer
into
electrochemical,
optical
molecularly
imprinted
polymers,
providing
insights
their
working
mechanisms
advantages
biomarker
identification.
Recent
innovations
are
highlighted
to
evaluate
current
state
sensor
technology
terms
selectivity,
sensitivity
real‐time
monitoring
capabilities.
Challenges
stability
issues,
biofouling
compliance
also
addressed.
The
underscores
transformative
potential
these
diagnostics,
role
enhancing
patient
care
through
convenient
point‐of‐care
healthcare
testing.
©
2025
Society
Chemical
Industry.
Язык: Английский
Advancements in Wearable and Implantable BioMEMS Devices: Transforming Healthcare Through Technology
Micromachines,
Год журнала:
2025,
Номер
16(5), С. 522 - 522
Опубликована: Апрель 28, 2025
Wearable
and
implantable
BioMEMSs
(biomedical
microelectromechanical
systems)
have
transformed
modern
healthcare
by
enabling
continuous,
personalized,
minimally
invasive
monitoring,
diagnostics,
therapy.
advanced
rapidly,
encompassing
a
diverse
range
of
biosensors,
bioelectronic
systems,
drug
delivery
platforms,
motion
tracking
technologies.
These
devices
enable
non-invasive,
real-time
monitoring
biochemical,
electrophysiological,
biomechanical
signals,
offering
personalized
proactive
solutions.
In
parallel,
BioMEMS
significantly
enhanced
long-term
targeted
delivery,
neurostimulation.
From
continuous
glucose
intraocular
pressure
to
programmable
bioelectric
implants
for
neuromodulation,
these
are
improving
precision
treatment
localized
This
review
explores
the
materials
technologies
driving
advancements
in
wearable
BioMEMSs,
focusing
on
their
impact
chronic
disease
management,
cardiology,
respiratory
care,
glaucoma
treatment.
We
also
highlight
integration
with
artificial
intelligence
(AI)
Internet
Things
(IoT),
paving
way
smarter,
data-driven
Despite
potential,
face
challenges
such
as
regulatory
complexities,
global
standardization,
societal
determinants.
Looking
ahead,
we
explore
emerging
directions
like
multifunctional
biodegradable
power
sources,
next-generation
point-of-care
diagnostics.
Collectively,
position
pivotal
enablers
future
patient-centric
systems.
Язык: Английский
Electrochemical approaches for breast cancer biomarkers: A voltammetric study of electrode potential scanning
Cell Reports Physical Science,
Год журнала:
2025,
Номер
unknown, С. 102569 - 102569
Опубликована: Май 1, 2025
Язык: Английский
Transdermal Patches: Design, Evaluation, and Potential Applications in Modern Therapeutics
Deleted Journal,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 16, 2025
Язык: Английский
Innovations in wearable biosensors: A pathway to 24/7 personalized healthcare
Measurement,
Год журнала:
2025,
Номер
unknown, С. 117938 - 117938
Опубликована: Май 1, 2025
Язык: Английский
Electrochemical nanosensors in therapeutic pharmaceutical monitoring: from drug followIng to clinical protocols
Electrochimica Acta,
Год журнала:
2025,
Номер
unknown, С. 146550 - 146550
Опубликована: Май 1, 2025
Язык: Английский
Real-Time and Highly Sensitive Detection of Matrix Metalloproteinase 9 (MMP-9) in Tears Using Aptamer Functionalized Electrolyte-Gated IGZO Thin-Film Transistors
ACS Applied Materials & Interfaces,
Год журнала:
2025,
Номер
unknown
Опубликована: Июнь 1, 2025
Dry
eye
disease
(DED)
is
a
common
disorder
characterized
by
unstable
tear
film
homeostasis.
Its
symptoms
range
from
foreign
body
sensations
to
pain
and
fluctuations
in
visual
function.
Current
diagnostics
include
physical
examination
ocular
surface
imaging.
Matrix
metalloproteinase-9
(MMP-9)
tears
correlates
with
clinical
signs
of
DED;
however,
because
the
limited
sample
volume,
quantitative
real-time
detection
MMP-9
significant
need,
complicated
biochemical
complexity
tears.
We
developed
an
ultrasensitive,
sensor
based
on
electrolyte-gated
indium-gallium-zinc
oxide
thin-film
transistors
(IGZO-EGTFTs),
capable
analyzing
submicroliter
volumes.
The
was
functionalized
at
nanoscale
improve
binding
capability
aptamer,
achieving
limit
1
fg/mL.
demonstrated
excellent
reproducibility
over
dynamic
spanning
8
orders
magnitude
up
100
ng/mL
(10-7
g/mL),
which
consistent
DED
patients.
Additionally,
sensing
performance
remained
stable
for
4
weeks,
highlighting
its
potential
future
commercial
applications.
concentration
human
samples
could
be
determined
real
time
high
sensitivity,
provides
promising
diagnostic
tools
early
detection,
progression
assessment,
timely
treatment
DED.
Язык: Английский